FIELD: medicine, pharmacy.
SUBSTANCE: invention refers to chemical and pharmaceutical industry, and is an amplifier for the antitumor effect of an antitumor agent, comprising imidazooxaazine compound represented by trans-3-amino-1-methyl-3-(4-(3-phenyl-5H-imidazo [1,2-c] pyrido [3,4-e] [1,3] oxazin-2-yl) phenyl)-cyclobutanol or trans-3-amino-1-cyclopropyl-3-(4- ( 3-phenyl-5H-imidazo [1,2-c] pyrido [4,3-e] [1,3] oxazin-2-yl)phenyl) cyclobutanol, or pharmaceutically acceptable salt thereof as an active ingredient. The invention also refers to pharmaceutical compositions, antitumor drugs containing the said compounds, applications, methods for the antitumor effect amplification and treatment of tumors.
EFFECT: invention provides a combined antitumor therapy, allowing to enhance the antitumor effect of anti tumor agents without substantial increase of toxicity.
18 cl, 77 ex, 22 tbl, 18 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL IMIDAZOOXAZINE COMPOUND OR SALT THEREOF | 2012 |
|
RU2578608C2 |
| BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES | 2009 |
|
RU2504547C2 |
| USING EP4 RECEPTOR LIGANDS IN TREATMENT OF IL-6-MEDIATED DISEASES | 2003 |
|
RU2285527C2 |
| DISPIROPYRROLIDINE DERIVATIVES | 2012 |
|
RU2612534C2 |
| IMIDAZOPYRIDIN-2-ONE DERIVATIVES, HAVING mTOR INHIBITING ACTIVITY | 2009 |
|
RU2478636C2 |
| 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEINKINASE INHIBITORS | 2005 |
|
RU2379308C2 |
| BICYCLIC COMPOUND AND USE THEREOF FOR SUV39H2 INHIBITION | 2016 |
|
RU2729187C1 |
| 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, METHOD FOR ITS OBTAINING AND ITS APPLICATION | 2019 |
|
RU2804127C2 |
| NEW HETEROAROMATIC AMIDE DERIVATIVE AND A MEDICINAL PRODUCT CONTAINING IT | 2019 |
|
RU2812959C2 |
| PYRROLO[2,3-D]PYRIMIDINE COMPOUND OR SALT THEREOF | 2016 |
|
RU2712269C2 |
